[Federal Register Volume 87, Number 207 (Thursday, October 27, 2022)]
[Notices]
[Pages 65070-65071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23379]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2022-N-1959]


Joint Meeting of the Nonprescription Drugs Advisory Committee and 
the Obstetrics, Reproductive and Urologic Drugs Advisory Committee; 
Postponement of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; postponement of meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is postponing the joint 
meeting of the Nonprescription Drugs Advisory Committee and the 
Obstetrics, Reproductive and Urologic Drugs Advisory Committee 
scheduled for November 18, 2022. Future meeting dates will be announced 
in the Federal Register.

FOR FURTHER INFORMATION CONTACT: Moon Choi, Center for Drug Evaluation 
and Research, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-796-2894, 
[email protected], or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area). Please call the 
Information Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: The joint meeting of the Nonprescription 
Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic 
Drugs

[[Page 65071]]

Advisory Committee was originally announced in the Federal Register of 
September 13, 2022 (87 FR 56071). The meeting has been postponed to 
allow time for FDA to review new information. Future meeting dates will 
be announced in the Federal Register.

    Dated: October 21, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-23379 Filed 10-26-22; 8:45 am]
BILLING CODE 4164-01-P


